Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

3.53
-0.3050-7.96%
Post-market: 3.550.0247+0.70%19:47 EDT
Volume:441.11K
Turnover:1.60M
Market Cap:122.26M
PE:-2.63
High:3.81
Open:3.80
Low:3.44
Close:3.83
Loading ...

Achieve Life Sciences Inc. Unveils Corporate Presentation on Transforming Public Health with New Nicotine Dependence Treatment

Reuters
·
30 May

Achieve Life Sciences Inc. Unveils Presentation on Transforming Public Health Through Smoking Cessation Solutions

Reuters
·
24 May

Achieve Life Sciences to present new data at 2025 ATS International Conference

TIPRANKS
·
20 May

Achieve Life Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Achieve Life Sciences Inc. Reports Q1 2025 Net Loss of $12.8 Million; Operating Expenses Reach $12.9 Million

Reuters
·
13 May

Achieve Life Sciences Q1 EPS $(0.37), Inline

Benzinga
·
13 May

Achieve Life Sciences Inc: Qtrly Loss per Share $0.37

THOMSON REUTERS
·
13 May

Achieve Life Sciences Q1 EPS USD -0.37 VS. Ibes Estimate USD -0.36

THOMSON REUTERS
·
13 May

Achieve Life Sciences Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
09 May

Achieve Life Sciences Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
05 May

Equity Markets Close Lower as Trump Calls on Fed for Rate Cuts

MT Newswires Live
·
22 Apr

BRIEF-Achieve Life Sciences Says Cytisinicline NDA Submission To FDA Planned For June 2025

Reuters
·
22 Apr

Achieve Life Sciences Expects to File New Drug Application in US for Smoking Cessation Medication

MT Newswires Live
·
22 Apr

Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial

TIPRANKS
·
21 Apr

Achieve Life Sciences Announces Cytisinicline Phase 3 Orca-3 Trial Publication on Smoking Cessation in Jama Internal Medicine

THOMSON REUTERS
·
21 Apr

Achieve Life Sciences Inc - Cytisinicline Nda Submission to FDA Planned for June 2025

THOMSON REUTERS
·
21 Apr

Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory

Insider Monkey
·
21 Mar

Q4 2024 Achieve Life Sciences Inc Earnings Call

Thomson Reuters StreetEvents
·
12 Mar

Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
12 Mar

Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Dexcom (DXCM)

TIPRANKS
·
12 Mar